FDA open to pooling data from ongoing Phase I/II studies of LX2006 with data from pivotal trial, and to earlier co-primary endpoint assessment, ...
ASX device and diagnostic companies are intensifying their measures to expedite product rollouts and approvals in the US.
Detailed price information for Cardiol Therapeutics Inc (CRDL-T) from The Globe and Mail including charting and trades.
Detailed price information for Solid Biosciences Inc (SLDB-Q) from The Globe and Mail including charting and trades.
Treatments for asthma, chronic rhinosinusitis with nasal polyps, dyslipidemia, Cushing syndrome, gonorrhea, HSCT-associated thrombotic microangiopathy, marginal zone lymphoma, motion sickness, ...
Engineers at MIT say they developed a flexible drug delivery patch for promoting healing and tissue regeneration after heart ...
Discover how Novo Nordisk's pipeline is being restructured to refocus its efforts on high-growth areas like diabetes and ...
News Medical on MSN
Smart Patch Boosts Heart Repair After Heart Attack
MIT engineers developed a programmable drug-delivery patch that can promote tissue healing and blood vessel regrowth ...
Refractory hydrocephalus (RH) refers to cases of fluid buildup in the brain that resist standard treatment, leading to ...
Zacks Small Cap Research on MSN
LGVN Looking Toward Commercialization
Its flagship product, Lomecel‑B (also known as laromestrocel), is an allogeneic medicinal-signaling cell (MSC) therapy derived from young healthy adult donors and manufactured under current good ...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results